These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5157211)
21. [Behavior of the 3rd and 4th complement fractions in chronic hepatitis]. Díaz-Rubio García M; Erroz A; Enríquez L; Arroyo MJ; Zamarrón A; Diáz Rubio M Rev Clin Esp; 1974 Aug; 134(3):237-42. PubMed ID: 4216050 [No Abstract] [Full Text] [Related]
22. [Quantitative correlation between C-reactive protein and other immunity factors in hepatic diseases]. Pérez Miranda M; Borda Celaya F; Ortíz de Landazúri E Rev Clin Esp; 1973 Jun; 130(1):19-28. PubMed ID: 4755582 [No Abstract] [Full Text] [Related]
23. Autoantibodies to collagen in patients with chronic liver diseases. Menzel EJ; Smolen JS; Renner F; Steffen C; Horak W Int Arch Allergy Appl Immunol; 1980; 63(4):425-30. PubMed ID: 7429654 [TBL] [Abstract][Full Text] [Related]
24. [HL-A antigen distribution in liver diseases]. Freudenberg J; Erdmann K; Meyer zum Büschenfelde ; Förster E; Berger J Verh Dtsch Ges Inn Med; 1973; 79():645-6. PubMed ID: 4790321 [No Abstract] [Full Text] [Related]
25. Serum complement in chronic liver disease. Potter BJ; Trueman AM; Jones EA Gut; 1973 Jun; 14(6):451-6. PubMed ID: 4737028 [TBL] [Abstract][Full Text] [Related]
26. Meningococcemia and acquired complement deficiency. Association in patients with hepatic failure. Ellison RT; Mason SR; Kohler PF; Curd JG; Reller LB Arch Intern Med; 1986 Aug; 146(8):1539-40. PubMed ID: 3729633 [TBL] [Abstract][Full Text] [Related]
27. Cryoglobulins in patients with acute hepatitis and inflammatory bowel disease. Levo Y Hepatogastroenterology; 1982 Dec; 29(6):246-8. PubMed ID: 7152458 [TBL] [Abstract][Full Text] [Related]
28. Typhoid hepatitis with immunoglobulins and complement deposits in bile canaliculi. Dan M; Bar-Meir S; Jedwab M; Shibolet S Arch Intern Med; 1982 Jan; 142(1):148-9. PubMed ID: 7053716 [TBL] [Abstract][Full Text] [Related]
29. Useful marker of hemolytic complement activity (CH50) for the diagnosis of severe acute hepatitis. Yoshida H; Satoh K; Ohkubo Y; Takagi T; Saito K; Morito T; Kasukawa R Fukushima J Med Sci; 1985 Jun; 31(1):43-8. PubMed ID: 3878823 [No Abstract] [Full Text] [Related]
31. Proceedings: C3 metabolism in HBsAg positive and negative chronic active liver disease (CALD). Elias E; Potter BJ; Thomas HC; Sherlock S Gut; 1976 May; 17(5):389. PubMed ID: 1278736 [No Abstract] [Full Text] [Related]
32. Australia antigen-antibody in hepatitis and other chronic liver disorder. Datta DV; Sehgal S; Schorber A J Assoc Physicians India; 1981 Jul; 29(7):527-9. PubMed ID: 7328075 [No Abstract] [Full Text] [Related]